Research graph
References from Iron and Other Metal Ions in Human Health and Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1073/pnas.22.4.210
10.1073/pnas.22.4.210 · External reference
Carbonic Anhydrase. Purification and Nature of the Enzyme
10.1042/bj0341163 · 1940 · External reference
10.1016/j.cell.2010.06.028
10.1016/j.cell.2010.06.028 · External reference
10.1089/ars.2007.1893
10.1089/ars.2007.1893 · External reference
Metalnet2: An Enhanced Server for Predicting Metal‐Binding Sites in Proteomes
10.1093/nsr/nwae391 · 2024 · External reference
10.1021/acs.jproteome.4c00271
10.1021/acs.jproteome.4c00271 · External reference
10.1016/j.tox.2011.03.001
10.1016/j.tox.2011.03.001 · External reference
Essential Metals in Health and Disease
10.1016/j.cbi.2022.110173 · 2022 · External reference
10.1038/s41392-023-01679-y
10.1038/s41392-023-01679-y · External reference
10.1016/j.cell.2021.03.033
10.1016/j.cell.2021.03.033 · External reference
10.1016/j.biocel.2006.07.001
10.1016/j.biocel.2006.07.001 · External reference
10.3390/nu17030454
10.3390/nu17030454 · External reference
10.1097/ms9.0000000000003100
10.1097/ms9.0000000000003100 · External reference
10.1001/jama.2025.0452
10.1001/jama.2025.0452 · External reference
10.3390/diagnostics14242789
10.3390/diagnostics14242789 · External reference
10.3390/ijms27020906
10.3390/ijms27020906 · External reference
10.1016/j.jtemb.2025.127727
10.1016/j.jtemb.2025.127727 · External reference
10.1002/jbt.70052
10.1002/jbt.70052 · External reference
10.3389/fnut.2022.717064
10.3389/fnut.2022.717064 · External reference
10.1155/2020/9207279
10.1155/2020/9207279 · External reference
Role of Zinc in Health and Disease
10.1007/s10238-024-01302-6 · 2024 · External reference
10.3390/antiox11050801
10.3390/antiox11050801 · External reference
10.1136/bmj.39582.589433.be
10.1136/bmj.39582.589433.be · External reference
10.1080/19396368.2023.2257352
10.1080/19396368.2023.2257352 · External reference
10.3390/cells13171490
10.3390/cells13171490 · External reference
10.1126/science.abf0529
10.1126/science.abf0529 · External reference
10.1016/j.cell.2012.03.042
10.1016/j.cell.2012.03.042 · External reference
10.1002/mco2.724
10.1002/mco2.724 · External reference
10.1016/j.cell.2017.09.021
10.1016/j.cell.2017.09.021 · External reference
10.1007/s12011-024-04289-z
10.1007/s12011-024-04289-z · External reference
Unlocking Iron: Nutritional Origins, Metabolic Pathways, and Systemic Significance
10.3389/fnut.2025.1637316 · 2025 · External reference
Supplements for Bone Health
2025 · External reference
10.1016/s0002-8223(01)00078-5
10.1016/s0002-8223(01)00078-5 · External reference
10.1111/pbi.12943
10.1111/pbi.12943 · External reference
10.1016/j.redox.2024.103211
10.1016/j.redox.2024.103211 · External reference
10.1111/j.1600-0609.2012.01782.x
10.1111/j.1600-0609.2012.01782.x · External reference
10.1113/ep085517
10.1113/ep085517 · External reference
Charge Transport Communication Through DNA by Protein Fe–S Clusters: How Far Is Not Too Far?
10.1021/acscentsci.8b00909 · 2019 · External reference
10.1016/j.bbamcr.2015.01.018
10.1016/j.bbamcr.2015.01.018 · External reference
Didox, a Ribonucleotide Reductase Inhibitor With Iron Chelator Properties, Counteracts the in Vitro and in Vivo Growth of Rhabdomyosarcoma Cells
10.1016/j.bcp.2025.117312 · 2025 · External reference
10.1021/jacsau.1c00078
10.1021/jacsau.1c00078 · External reference
10.1016/j.str.2026.03.006
10.1016/j.str.2026.03.006 · External reference
Introduction: Metals in Biology: Α‐Ketoglutarate/Iron‐Dependent Dioxygenases
10.1074/jbc.r115.675652 · 2015 · External reference
10.1038/nature04433
10.1038/nature04433 · External reference
10.1038/nrg1945
10.1038/nrg1945 · External reference
Iron Overload Disorders in Adults: A Comprehensive Review of Gonadal Function, Reproductive, and Sexual Health
10.1093/humupd/dmag010 · 2026 · External reference
10.3345/cep.2025.02957
10.3345/cep.2025.02957 · External reference
Iron Deficiency Anemia Reduces Thyroid Peroxidase Activity in Rats
10.1093/jn/132.7.1951 · 2002 · External reference
Crosstalk Between Ferroptosis and Mirna in Type 2 Diabetes Mellitus and Possible Therapeutic Targeting
10.1186/s40001-025-03178-y · 2025 · External reference
10.1096/fj.202600188r
10.1096/fj.202600188r · External reference
10.3390/cells10112841
10.3390/cells10112841 · External reference
Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus
10.1155/2021/9999612 · 2021 · External reference
Trace Element Copper in Male and Female Reproduction: A Review
2022 · External reference
10.3390/ijms21239053
10.3390/ijms21239053 · External reference
10.4161/21675511.2014.974982
10.4161/21675511.2014.974982 · External reference
10.3233/trd-170015
10.3233/trd-170015 · External reference
10.3390/ijms23169316
10.3390/ijms23169316 · External reference
10.1038/s41574-018-0042-0
10.1038/s41574-018-0042-0 · External reference
10.1016/j.fertnstert.2024.11.007
10.1016/j.fertnstert.2024.11.007 · External reference
10.1016/j.maturitas.2020.11.004
10.1016/j.maturitas.2020.11.004 · External reference
10.1152/physrev.00035.2014
10.1152/physrev.00035.2014 · External reference
10.3390/biom10081164
10.3390/biom10081164 · External reference
Antioxidant Vitamin and Mineral Supplements for Slowing the Progression of Age‐related Macular Degeneration
2023 · External reference
A Randomized, Placebo‐Controlled, Clinical Trial of High‐Dose Supplementation with Vitamins C and E and Beta Carotene for Age‐Related Cataract and Vision Loss
10.1001/archopht.119.10.1439 · 2001 · External reference
Long‐Term Effects of Vitamins C and E, β‐Carotene, and Zinc on Age‐Related Macular Degeneration
10.1016/j.ophtha.2013.01.021 · 2013 · External reference
10.3389/fnsyn.2018.00011
10.3389/fnsyn.2018.00011 · External reference
10.3390/ph16010001
10.3390/ph16010001 · External reference
10.1016/j.celrep.2019.12.002
10.1016/j.celrep.2019.12.002 · External reference
10.1038/srep00129
10.1038/srep00129 · External reference
10.1007/bf02829935
10.1007/bf02829935 · External reference
Regulation and Function of ZIP4 , the Acrodermatitis Enteropathica Gene
10.1042/bst0361242 · 2008 · External reference
10.4162/nrp.2007.1.2.113
10.4162/nrp.2007.1.2.113 · External reference
10.1111/brv.12764
10.1111/brv.12764 · External reference
10.1016/j.cmet.2024.10.021
10.1016/j.cmet.2024.10.021 · External reference
10.1016/j.cell.2012.10.011
10.1016/j.cell.2012.10.011 · External reference
10.1002/embr.201337946
10.1002/embr.201337946 · External reference
10.3892/br.2016.785
10.3892/br.2016.785 · External reference
10.1074/jbc.m001087200
10.1074/jbc.m001087200 · External reference
Unresolved reference
2000 · External reference
Diagnosis and Management of Hyperparathyroidism
10.1001/jamainternmed.2019.5129 · 2019 · External reference
Epidemiology and Diagnosis of Hypoparathyroidism
10.1210/jc.2015-3908 · 2016 · External reference
Hypomagnesemia in Patients With Type 2 Diabetes Mellitus
10.59556/japi.72.0410 · 2024 · External reference
Chronic Symptomatic Hypocalcaemia—Difficulties in Diagnosis and Treatment in Rural Africa
10.1258/td.2010.100166 · 2010 · External reference
Management of Iron Deficiency Anemia and the Role of Intravenous Iron Supplementation in Patients Undergoing Cancer Chemotherapy: A Real‐World Retrospective Study in Japan
10.1007/s10147-026-03057-4 · 2026 · External reference
10.1111/ejh.70211
10.1111/ejh.70211 · External reference
10.1038/s41420-022-01212-0
10.1038/s41420-022-01212-0 · External reference
Iron Excretion in Iron Dextran‐Overloaded Mice
2014 · External reference
10.1016/j.toxlet.2015.10.027
10.1016/j.toxlet.2015.10.027 · External reference
10.3390/nu17162714
10.3390/nu17162714 · External reference
10.1016/j.jtemb.2025.127808
10.1016/j.jtemb.2025.127808 · External reference
Rapid Onset of Iron Overload Cardiomyopathy in Cirrhosis
2026 · External reference
Assessing Causal Relationships Between Iron Level, Disorders of Iron Metabolism, and Hepatocellular Carcinoma: A Mendelian Randomisation Study: The First Author
10.1007/s12672-025-03086-x · 2026 · External reference
10.1182/blood-2018-06-815894
10.1182/blood-2018-06-815894 · External reference
10.1016/j.cpcardiol.2024.102911
10.1016/j.cpcardiol.2024.102911 · External reference
10.1111/pedi.12793
10.1111/pedi.12793 · External reference
10.3390/ijms242216263
10.3390/ijms242216263 · External reference
10.1016/j.fertnstert.2007.07.1342
10.1016/j.fertnstert.2007.07.1342 · External reference
10.1016/j.neuro.2009.08.008
10.1016/j.neuro.2009.08.008 · External reference
Myelopolyneuropathy and Pancytopenia Due to Copper Deficiency and High Zinc Levels of Unknown Origin
10.1001/archneur.60.9.1303 · 2003 · External reference
Copper Deficiency Myelopathy Induced by Excessive Zinc Supplementation
10.1136/pn-2025-004785 · 2026 · External reference
Copper in Human Health and Disease: Insights From Inherited Disorders
2026 · External reference
10.1016/j.cbi.2026.112007
10.1016/j.cbi.2026.112007 · External reference
Zinc Deficiency as Possible Link Between Immunosenescence and Age‐Related Diseases
10.1186/s12979-025-00511-1 · 2025 · External reference
10.1007/s12011-023-03818-6
10.1007/s12011-023-03818-6 · External reference
10.3390/biom14070863
10.3390/biom14070863 · External reference
Acrodermatitis Enteropathica
10.1001/jamadermatol.2023.4147 · 2024 · External reference
10.3390/nu12030762
10.3390/nu12030762 · External reference
Acrodermatitis Enteropathica in the Pediatric Population: A Literature Review of Real‐World Studies
10.3389/fnut.2025.1590075 · 2025 · External reference
Acquired Acrodermatitis Enteropathica
10.1016/j.amjmed.2020.09.011 · 2021 · External reference
10.3390/nu12051500
10.3390/nu12051500 · External reference
10.1016/j.nbd.2025.107115
10.1016/j.nbd.2025.107115 · External reference
Mutations in SLC39A14 Disrupt Manganese Homeostasis and Cause Childhood‐Onset Parkinsonism–Dystonia
10.1038/ncomms11601 · 2016 · External reference
SLC‐30A9 Is Required for Zn2+ Homeostasis, Zn2+ Mobilization, and Mitochondrial Health
10.1073/pnas.2023909118 · 2021 · External reference
The Metallome as a Link Between the “Omes” in Autism Spectrum Disorders
10.3389/fnmol.2021.695873 · 2021 · External reference
10.1136/jcp-2024-209463
10.1136/jcp-2024-209463 · External reference
10.2147/ndt.s407731
10.2147/ndt.s407731 · 2023 · External reference
Randomized, Controlled Clinical Trial of Zinc Supplementation to Prevent Immunological Failure in HIV‐Infected Adults
10.1086/652864 · 2010 · External reference
10.1371/journal.pone.0251554
10.1371/journal.pone.0251554 · External reference
10.1007/s11938-017-0132-4
10.1007/s11938-017-0132-4 · External reference
10.3390/diagnostics12092045
10.3390/diagnostics12092045 · External reference
10.1007/s00277-025-06429-4
10.1007/s00277-025-06429-4 · External reference
Gata Zinc Finger Domain‐Containing Protein 2a (GATAD2A) Deficiency Reactivates Fetal Haemoglobin in Patients With Beta‐Thalassaemia Through Impaired Formation of Methyl‐Binding Domain Protein 2 (MBD2)‐Containing Nucleosome Remodelling and Deacetylation (NURD) Complex
10.1111/bjh.17511 · 2021 · External reference
Zinc in Denture Adhesive: A Rare Cause of Copper Deficiency in a Patient on Home Parenteral Nutrition
10.1136/bcr-2015-211390 · 2015 · External reference
Unresolved reference
2026 · External reference
10.3390/molecules29133130
10.3390/molecules29133130 · External reference
10.1159/000512612
10.1159/000512612 · External reference
Acquired Hyperzincaemia Due to Zinc‐Laden Denture Adhesives Leading to Hypocupraemia as a Cause of Neutropenia
2021 · External reference
10.1111/bcp.15749
10.1111/bcp.15749 · External reference
Zinc‐induced Copper Deficiency as a Rare Cause of Neurological Deficit and Anemia
2023 · External reference
Adam17 as a Promising Therapeutic Target: From Structural Basis to Inhibitor Discovery in Human Diseases
10.3389/fphar.2025.1640090 · 2025 · External reference
10.1080/14728222.2017.1386176
10.1080/14728222.2017.1386176 · External reference
10.3390/antiox7120191
10.3390/antiox7120191 · External reference
10.1155/2020/3464068
10.1155/2020/3464068 · External reference
10.1007/s10787-017-0309-4
10.1007/s10787-017-0309-4 · External reference
10.1093/jn/131.12.3182
10.1093/jn/131.12.3182 · External reference
10.18632/aging.203831
10.18632/aging.203831 · External reference
10.1007/s11357-021-00393-3
10.1007/s11357-021-00393-3 · External reference
10.1002/jbmr.483
10.1002/jbmr.483 · External reference
Palatoschisis, Schizophrenia and Hypocalcaemia: Phenotypic Expression of 22q11.2 Deletion Syndrome (digeorge syndrome) in an Adult
2021 · External reference
Autoimmune Polyendocrine Syndromes: Recognizing the Overlooked Clusters of Endocrinopathies
2025 · External reference
10.1016/j.tem.2016.05.005
10.1016/j.tem.2016.05.005 · External reference
Mitochondrial Dysfunction in Alzheimer's Disease and Related Sex Differences
10.3389/fnagi.2026.1761702 · 2026 · External reference
10.1093/hmg/ddab363
10.1093/hmg/ddab363 · External reference
10.1016/j.intimp.2022.109614
10.1016/j.intimp.2022.109614 · External reference
10.1111/acel.13834
10.1111/acel.13834 · External reference
10.1111/cns.14157
10.1111/cns.14157 · External reference
10.1038/onc.2013.192
10.1038/onc.2013.192 · External reference
10.15252/embr.202050827
10.15252/embr.202050827 · External reference
10.1007/s00424-017-2057-0
10.1007/s00424-017-2057-0 · External reference
10.1016/j.celrep.2015.06.033
10.1016/j.celrep.2015.06.033 · External reference
10.1126/science.1127883
10.1126/science.1127883 · External reference
10.1128/mcb.22.6.1734-1741.2002
10.1128/mcb.22.6.1734-1741.2002 · External reference
10.1038/nature06905
10.1038/nature06905 · External reference
10.1080/15548627.2020.1850609
10.1080/15548627.2020.1850609 · External reference
10.1038/s41418-022-01095-9
10.1038/s41418-022-01095-9 · External reference
Mitochondrial Ca2+‐Dependent NLRP3 Activation Exacerbates the pseudomonas Aeruginosa‐Driven Inflammatory Response in Cystic Fibrosis
10.1038/ncomms7201 · 2015 · External reference
Pharmacological Modulation of Mitochondrial Calcium Uniporter Controls Lung Inflammation in Cystic Fibrosis
10.1126/sciadv.aax9093 · 2020 · External reference
High Fructose Causes Cardiac Hypertrophy via Mitochondrial Signaling Pathway
2016 · External reference
10.3390/nu10070836
10.3390/nu10070836 · External reference
10.3389/fphar.2021.581645
10.3389/fphar.2021.581645 · External reference
10.1016/j.yjmcc.2014.08.015
10.1016/j.yjmcc.2014.08.015 · External reference
10.1016/j.ijcard.2016.07.125
10.1016/j.ijcard.2016.07.125 · External reference
10.1111/eci.14331
10.1111/eci.14331 · External reference
10.1016/j.celrep.2021.108983
10.1016/j.celrep.2021.108983 · External reference
Endothelial MICU1 Protects Against Vascular Inflammation and Atherosclerosis by Inhibiting Mitochondrial Calcium Uptake
10.1172/jci181928 · 2025 · External reference
Cardiovascular Homeostasis Dependence on MICU2, a Regulatory Subunit of the Mitochondrial Calcium Uniporter
2017 · External reference
10.1186/s10020-023-00656-z
10.1186/s10020-023-00656-z · External reference
Koumine Mediates the Generation of MTROS Through the IP3R1‐GRP75‐VDAC1 Complex to Improve Citrinin Induced Intestinal Inflammation
10.1016/j.phymed.2025.156803 · 2025 · External reference
10.1152/ajpgi.00071.2013
10.1152/ajpgi.00071.2013 · External reference
10.1002/ibd.21868
10.1002/ibd.21868 · External reference
10.4049/jimmunol.1601293
10.4049/jimmunol.1601293 · External reference
10.1016/j.cellsig.2014.06.006
10.1016/j.cellsig.2014.06.006 · External reference
10.1016/j.mito.2013.01.003
10.1016/j.mito.2013.01.003 · External reference
10.3748/wjg.v22.i42.9300
10.3748/wjg.v22.i42.9300 · External reference
10.1038/cdd.2014.35
10.1038/cdd.2014.35 · External reference
Zinc Homeostasis in Malawian Children Consuming a High‐Phytate, Maize‐Based Diet
10.1093/ajcn/75.6.1057 · 2002 · External reference
Copper Deficiency Presenting With Bicytopenia During Long‐Term Parenteral Nutrition for Short Bowel Syndrome: A Case Report and Literature Review
2025 · External reference
10.4103/nrr.nrr-d-24-00110
10.4103/nrr.nrr-d-24-00110 · External reference
10.1016/j.scitotenv.2025.179785
10.1016/j.scitotenv.2025.179785 · External reference
10.1016/j.buildenv.2024.112357
10.1016/j.buildenv.2024.112357 · External reference
10.1007/s10661-025-13963-1
10.1007/s10661-025-13963-1 · External reference
Developmental Pb Exposure Increases Rate of Forgetting on a Delayed Matching‐to‐Sample Task Among Mexican Children
10.1126/sciadv.adq4495 · 2025 · External reference
10.1016/j.ecoenv.2025.117792
10.1016/j.ecoenv.2025.117792 · External reference
Effects of Prenatal Arsenic, Cadmium, and Manganese Exposure on Neurodevelopment in Children: A Systematic Review and Meta‐Analysis
10.3390/medicina61071143 · 2025 · External reference
Neurodevelopmental Outcomes Associated With Early‐Life Exposure to Heavy Metals: A Systematic Review
10.3390/ijerph22081308 · 2025 · External reference
Effects of Blood Lead Levels <10 Microg/Dl in School‐Age Children and Adolescents: A Scoping Review
10.1542/peds.2024-067808f · 2024 · External reference
10.3390/ijms25126662
10.3390/ijms25126662 · External reference
10.1155/2013/259189
10.1155/2013/259189 · External reference
10.1210/clinem/dgae769
10.1210/clinem/dgae769 · External reference
10.1210/en.2015-1269
10.1210/en.2015-1269 · External reference
Transient Hyperparathyroidism and Severe Intrauterine Osteopenia Linked to Novel Homozygous TRPV6 Deletion
10.1111/cen.70134 · 2026 · External reference
10.1186/s12576-020-00761-2
10.1186/s12576-020-00761-2 · External reference
10.1007/s00467-018-3998-z
10.1007/s00467-018-3998-z · External reference
Antenatal Presentation and Early Postnatal Treatment of Infantile Hypercalcemia Type 2
10.1007/s00467-024-06403-8 · 2024 · External reference
10.1155/2018/3068365
10.1155/2018/3068365 · External reference
10.1002/ccr3.71530
10.1002/ccr3.71530 · External reference
Zinc Supplementation for Improving Pregnancy and Infant Outcome
2021 · External reference
10.1146/annurev-nutr-061021-030404
10.1146/annurev-nutr-061021-030404 · External reference
10.1007/s12011-023-03716-x
10.1007/s12011-023-03716-x · External reference
Heavy Metals as Endocrine Disruptors
10.55730/1300-0144.6132 · 2026 · External reference
10.1016/j.jnutbio.2009.01.009
10.1016/j.jnutbio.2009.01.009 · External reference
10.1093/nutrit/nuad091
10.1093/nutrit/nuad091 · External reference
Effects of Folic Acid With Vitamin b12/Vitamin b6 Intervention on Serum Homocysteine Metabolism and Complications in Patients With Type 2 Diabetes: A Systematic Review and Meta‐analysis of Randomized Controlled Trials
10.3389/fnut.2025.1701310 · 2025 · External reference
10.1182/blood-2004-01-0177
10.1182/blood-2004-01-0177 · External reference
10.1016/s1474-4422(14)70190-5
10.1016/s1474-4422(14)70190-5 · External reference
Diagnosis and Management of Patients With Hypercalcaemia
10.7748/nop.27.4.22.e685 · 2015 · External reference
10.1136/ard.2010.139105
10.1136/ard.2010.139105 · External reference
10.1007/s00198-016-3716-2
10.1007/s00198-016-3716-2 · External reference
10.1016/j.mce.2013.08.002
10.1016/j.mce.2013.08.002 · External reference
Endocrine Complications in Patients With β‐Thalassemia Major Receiving Iron‐Chelation Therapy
10.1177/20420188251406554 · 2025 · External reference
10.1111/j.1749-6632.2010.05583.x
10.1111/j.1749-6632.2010.05583.x · External reference
10.1182/blood-2011-06-360271
10.1182/blood-2011-06-360271 · External reference
10.1111/j.1365-2141.2009.07970.x
10.1111/j.1365-2141.2009.07970.x · External reference
Bone Disease in Thalassaemia Major: Recent Advances in Pathogenesis and Clinical Aspects
2011 · External reference
10.1111/andr.12770
10.1111/andr.12770 · External reference
10.1530/eje-11-0215
10.1530/eje-11-0215 · External reference
Hypogonadism and Sexual Dysfunction in Hemochromatosis: The Effects of Cirrhosis and Diabetes
10.1210/jcem-69-1-110 · 1989 · External reference
Hypoparathyroidism in Adults With Iron Overload Diseases (IOD): Evidence of a Subclinical Phenotype
10.1007/s12020-024-04124-4 · 2025 · External reference
10.3390/molecules28237707
10.3390/molecules28237707 · External reference
10.1016/s0016-5085(98)70538-4
10.1016/s0016-5085(98)70538-4 · External reference
Iron Deposition in the Anterior Pituitary in Homozygous Beta‐thalassemia: MRI Evaluation and Correlation With Gonadal Function
10.1515/jpem.2000.13.2.179 · 2000 · External reference
10.1080/03630269.2020.1812636
10.1080/03630269.2020.1812636 · External reference
10.1002/ajh.22223
10.1002/ajh.22223 · External reference
10.1053/euhj.2001.2822
10.1053/euhj.2001.2822 · External reference
10.3324/haematol.11768
10.3324/haematol.11768 · External reference
10.1097/mph.0000000000000767
10.1097/mph.0000000000000767 · External reference
10.1007/s00277-016-2841-5
10.1007/s00277-016-2841-5 · External reference
10.1007/bf03346513
10.1007/bf03346513 · External reference
10.1210/clinem/dgaf191
10.1210/clinem/dgaf191 · External reference
10.3389/fphar.2017.00077
10.3389/fphar.2017.00077 · External reference
10.59556/japi.73.1029
10.59556/japi.73.1029 · External reference
10.1006/bcmd.2002.0536
10.1006/bcmd.2002.0536 · External reference
10.1016/j.medcli.2024.05.015
10.1016/j.medcli.2024.05.015 · External reference
10.1016/j.tjnut.2026.101393
10.1016/j.tjnut.2026.101393 · External reference
Dha Ameliorates Gdm Placental Angiogenesis by Regulating Hamp‐Mediated Iron Imbalance
10.2991/978-94-6239-703-3 · 2026 · External reference
10.1007/s12288-021-01442-9
10.1007/s12288-021-01442-9 · External reference
Slc40a1 (iron transporter): Mechanistic Regulation, Role in Disease Pathogenesis, and Prospects for Targeted Therapy
10.3389/fcell.2026.1816800 · 2026 · External reference
Downregulation of SLC40A1 Leads to Iron Accumulation in Fibrotic Lung Fibroblasts
10.1186/s12931-025-03479-0 · 2026 · External reference
10.12998/wjcc.v5.i10.381
10.12998/wjcc.v5.i10.381 · External reference
TFR2‐Related Haemochromatosis in the Netherlands: A Cause of Arthralgia in Young Adulthood
2017 · External reference
Early‐Onset Haemochromatosis Caused by a Novel Combination of TFR2 Mutations(p.R396x/c.1538‐2 a>g) in a Woman of Italian Descent
10.3324/haematol.12884 · 2008 · External reference
10.1038/75534
10.1038/75534 · External reference
Ferroportin Disease: A Novel SLC40A1 Mutation
10.1016/j.dld.2020.03.013 · 2020 · External reference
HJV Mutations Causing Hemochromatosis: Variable Phenotypic Expression in a Pair of Twins
10.3324/haematol.2023.284134 · 2024 · External reference
Mean Corpuscular Volume in HFE p.C282Y/p.H63D Compound Heterozygotes with High Iron Phenotypes: Clinical and Laboratory Associations
10.14740/jh2155 · 2026 · External reference
10.1016/j.heliyon.2024.e28046
10.1016/j.heliyon.2024.e28046 · External reference
10.1002/ajh.21524
10.1002/ajh.21524 · External reference
The Quiet Burden of Iron: A Rare Case of Hereditary Hemochromatosis in Pakistan
2025 · External reference
10.1016/j.jhep.2018.03.019
10.1016/j.jhep.2018.03.019 · External reference
10.1080/20009666.2017.1351289
10.1080/20009666.2017.1351289 · External reference
Bilateral Dense Kayser‐Fleischer Rings in Wilson's Disease
2026 · External reference
Neurological Manifestations of Wilson's Disease: Pathophysiology and Localization of Each Component
2020 · External reference
10.3390/ijms22157820
10.3390/ijms22157820 · External reference
10.1016/j.cca.2011.08.019
10.1016/j.cca.2011.08.019 · External reference
10.1002/jimd.70024
10.1002/jimd.70024 · External reference
10.1002/jmri.26984
10.1002/jmri.26984 · External reference
10.3390/brainsci14070727
10.3390/brainsci14070727 · External reference
10.1016/j.parkreldis.2022.105247
10.1016/j.parkreldis.2022.105247 · External reference
Wilson's Disease in Childhood and the Challenges in Its Diagnosis: A Case Report
2024 · External reference
10.1016/j.jceh.2025.102531
10.1016/j.jceh.2025.102531 · External reference
EASL‐ERN Clinical Practice Guidelines on Wilson's Disease
2025 · External reference
Mutation Analysis of the ATP7B Gene and Genotype–Phenotype Correlation in Chinese Patients With Wilson Disease
10.1186/s12876-021-01911-5 · 2021 · External reference
10.1371/journal.pone.0269833
10.1371/journal.pone.0269833 · External reference
Unfavorable Switching of Skewed X Chromosome Inactivation Leads to Menkes Disease in a Female Infant
10.1038/s41598-023-50668-2 · 2024 · External reference
10.1136/bcr-2024-259792
10.1136/bcr-2024-259792 · External reference
Intravenous AAV9‐ATP7A Plus Subcutaneous Copper Histidinate Optimizes Outcomes in a Lethal Menkes Disease Mouse Model
10.1126/sciadv.adw5612 · 2025 · External reference
Diagnosis and Clinical Associations of Zinc Depletion Following Bone Marrow Transplantation
10.1136/adc.74.4.328 · 1996 · External reference
Assessment of Hair Zinc in the School Children in Kayseri, Turkey
10.1007/s12011-020-02115-w · 2020 · External reference
10.1016/j.envint.2020.105584
10.1016/j.envint.2020.105584 · External reference
10.1179/2045772314y.0000000268
10.1179/2045772314y.0000000268 · External reference
10.1016/j.molmet.2021.101245
10.1016/j.molmet.2021.101245 · External reference
10.1002/ajmg.a.70131
10.1002/ajmg.a.70131 · External reference
10.1212/wnl.0000000000207241
10.1212/wnl.0000000000207241 · External reference
10.1093/brain/awx013
10.1093/brain/awx013 · External reference
Metal Fume Fever: A Review of the Literature and Cases Reported to the Louisiana Poison Control Center
2009 · External reference
10.3109/15563650.2015.1013548
10.3109/15563650.2015.1013548 · External reference
10.1016/j.ecl.2018.07.004
10.1016/j.ecl.2018.07.004 · External reference
Transient Hypercalcemia in Preterm Infants: Insights Into Natural History and Laboratory Evaluation
10.1177/2333794x14560818 · 2014 · External reference
10.1002/1097-0142(19890301)63:5<917::aid-cncr2820630522>3.0.co;2-e
10.1002/1097-0142(19890301)63:5<917::aid-cncr2820630522>3.0.co;2-e · External reference
Evaluation of a Laboratory Critical Limit (Alert Value) Policy for Hypercalcemia
1996 · External reference
Biochemical Association Between Calcium Homeostasis and Serum Uric Acid Levels in Patients With Hypothyroidism: A Comparative Evaluation With 25‐Hydroxyvitamin D
2025 · External reference
Vitamin D Deficiency and the Presentation of Primary Hyperparathyroidism: A Mini Review
10.1155/2023/1169249 · 2023 · External reference
Unveiling the Complexities of Hypoparathyroidism: A Comprehensive Review of Clinical Manifestations, Diagnosis, and Novel Therapies
10.1007/s40618-025-02760-9 · 2026 · External reference
10.1359/jbmr.1999.14.8.1255
10.1359/jbmr.1999.14.8.1255 · External reference
Usefulness of X‐Rays in the Differential Diagnosis of Hypophosphataemic Rickets
10.1007/s12325-019-01183-2 · 2020 · External reference
Idiopathic Basal Ganglia Calcification: Fahr's Syndrome, a Rare Disorder
2019 · External reference
Clinical and Genetic Characteristics of Hypoparathyroidism in Children: A Multicenter Experience in China
10.1007/s40618-024-02465-5 · 2025 · External reference
10.1053/j.gastro.2010.06.013
10.1053/j.gastro.2010.06.013 · External reference
10.1210/er.2016-1070
10.1210/er.2016-1070 · External reference
A Practical Approach to Hypercalcemia
2003 · External reference
10.1681/asn.2010030255
10.1681/asn.2010030255 · External reference
10.1001/jama.2022.18331
10.1001/jama.2022.18331 · External reference
10.1136/bmj.h2723
10.1136/bmj.h2723 · External reference
Diagnosis and Management of Primary Hyperparathyroidism: Recommendations From the Bone Section of the hellenic Endocrine Society
10.1007/s42000-025-00681-z · 2025 · External reference
Unresolved reference
2026 · External reference
Cancer‐Associated Hypercalcemia
10.1056/nejmc2206287 · 2022 · External reference
10.1056/nejmcp2113128
10.1056/nejmcp2113128 · External reference
10.1097/00063198-200009000-00010
10.1097/00063198-200009000-00010 · External reference
Hypercalcemia of Malignancy: Mechanisms and Therapeutic Implications of Concurrently Elevated PTHRP and Calcitriol
10.1210/jendso/bvaf104 · 2025 · External reference
Clinical Presentation of Primary Hyperparathyroidism in Older Adults
10.1210/js.2019-00316 · 2019 · External reference
Calcium Sensing Receptor Expression and Signalling in Cardiovascular Physiology and Disease
10.1016/j.vph.2018.02.007 · 2018 · External reference
10.1146/annurev-physiol-020911-153318
10.1146/annurev-physiol-020911-153318 · External reference
10.1016/s1877-1173(09)89003-0
10.1016/s1877-1173(09)89003-0 · External reference
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
10.1210/jc.2013-1204 · 2013 · External reference
10.1136/ard.2010.139360
10.1136/ard.2010.139360 · External reference
Calcium Pyrophosphate Deposition Disease
10.1503/cmaj.250933 · 2026 · External reference
10.2147/oarrr.s389664
10.2147/oarrr.s389664 · 2023 · External reference
Calcium Pyrophosphate Crystal Deposition Disease: Diagnosis and Treatment
10.2147/oarrr.s39039 · 2014 · External reference
Clinical, Radiographic and Pathologic Abnormalities in Calcium Pyrophosphate Dihydrate Deposition Disease (cppd): Pseudogout
10.1148/122.1.1 · 1977 · External reference
Imaging of Calcium Pyrophosphate Deposition Disease
10.1007/s11926-015-0496-1 · 2015 · External reference
10.1016/j.joca.2019.01.015
10.1016/j.joca.2019.01.015 · External reference
Dual‐Energy Computed‐tomography‐Based Discrimination Between Basic Calcium Phosphate and Calcium Pyrophosphate Crystal Deposition in Vivo
10.1177/1759720x20936060 · 2020 · External reference
10.1016/j.jbspin.2017.09.006
10.1016/j.jbspin.2017.09.006 · External reference
10.1097/bor.0000000000000142
10.1097/bor.0000000000000142 · External reference
10.1093/rheumatology/keac479
10.1093/rheumatology/keac479 · External reference
10.3899/jrheum.161057
10.3899/jrheum.161057 · External reference
10.1002/acr.22190
10.1002/acr.22190 · External reference
10.1136/annrheumdis-2020-217998
10.1136/annrheumdis-2020-217998 · External reference
10.1007/s00256-005-0930-y
10.1007/s00256-005-0930-y · External reference
Autosomal Dominant Familial Calcium Pyrophosphate Dihydrate Deposition Disease Is Caused by Mutation in the Transmembrane Protein Ankh
10.1086/343053 · 2002 · External reference
10.1086/343054
10.1086/343054 · External reference
Survival and Complications in Patients With Thalassemia Major Treated With Transfusion and Deferoxamine
2004 · External reference
10.1111/j.1365-2141.2009.07793.x
10.1111/j.1365-2141.2009.07793.x · External reference
10.1093/ejechocard/jeq190
10.1093/ejechocard/jeq190 · External reference
10.1007/s40618-019-01072-z
10.1007/s40618-019-01072-z · External reference
10.2147/jbm.s27400
10.2147/jbm.s27400 · External reference
10.1093/sxmrev/qeae062
10.1093/sxmrev/qeae062 · External reference
10.3109/00016349509024430
10.3109/00016349509024430 · External reference
10.1097/gco.0b013e32833e4a35
10.1097/gco.0b013e32833e4a35 · External reference
10.1038/ncb3064
10.1038/ncb3064 · External reference
10.1016/j.lfs.2023.122370
10.1016/j.lfs.2023.122370 · External reference
10.1093/molehr/gaz015
10.1093/molehr/gaz015 · External reference
10.1016/j.jtemb.2021.126794
10.1016/j.jtemb.2021.126794 · External reference
10.1021/acsami.5c18528
10.1021/acsami.5c18528 · External reference
10.1111/andr.13729
10.1111/andr.13729 · External reference
10.1016/j.expneurol.2024.114862
10.1016/j.expneurol.2024.114862 · External reference
10.1016/j.gendis.2024.101262
10.1016/j.gendis.2024.101262 · External reference
10.1016/j.intimp.2024.112800
10.1016/j.intimp.2024.112800 · External reference
10.1016/j.jdermsci.2024.07.005
10.1016/j.jdermsci.2024.07.005 · External reference
10.1016/j.bbrc.2024.150436
10.1016/j.bbrc.2024.150436 · External reference
10.1016/j.redox.2025.103557
10.1016/j.redox.2025.103557 · External reference
10.1016/j.ijpddr.2025.100630
10.1016/j.ijpddr.2025.100630 · External reference
10.1007/s10753-024-02022-5
10.1007/s10753-024-02022-5 · External reference
10.1007/s12013-024-01315-8
10.1007/s12013-024-01315-8 · External reference
10.1007/s11626-025-01088-1
10.1007/s11626-025-01088-1 · External reference
Integrated Hepatic Ferroptosis Gene Signature Dictates Pathogenic Features of Ferroptosis
10.1097/hc9.0000000000000721 · 2025 · External reference
Early Pathological Changes in the Liver and Kidney of Non‐Obese Diabetic (NOD) Mice: Involvement of Iron Accumulation and Ferroptosis
10.3389/fendo.2025.1673012 · 2025 · External reference
10.3390/ijms25115890
10.3390/ijms25115890 · External reference
Identification and Validation of Cuproptosis‐Related Genes in Acetaminophen‐Induced Liver Injury Using Bioinformatics Analysis and Machine Learning
10.3389/fimmu.2024.1371446 · 2024 · External reference
10.1038/s41467-024-48227-y
10.1038/s41467-024-48227-y · External reference
10.1186/s12989-025-00633-w
10.1186/s12989-025-00633-w · External reference
Reduced Glutathione Ameliorates Sepsis‐Induced Acute Kidney Injury in Mouse Model: Involvement of Cuproptosis
10.1080/0886022x.2025.2518227 · 2025 · External reference
10.1016/j.freeradbiomed.2025.04.022
10.1016/j.freeradbiomed.2025.04.022 · External reference
10.1155/ijcp/6675290
10.1155/ijcp/6675290 · External reference
10.2147/jir.s512187
10.2147/jir.s512187 · 2025 · External reference
Suppressing Chondrocyte Cuproptosis by Syringaresinol‐4‐O‐β‐D‐Glucoside Alleviates Gouty Arthritis
10.3389/fphar.2025.1565422 · 2025 · External reference
Aberrant Copper Metabolism and Hepatic Inflammation Cause Neurological Manifestations in a Mouse Model of Wilson's Disease
10.1186/s12974-024-03178-5 · 2024 · External reference
10.1152/ajpheart.00025.2024
10.1152/ajpheart.00025.2024 · External reference
10.1016/j.bbagen.2023.130518
10.1016/j.bbagen.2023.130518 · External reference
Xenotransplanted Human Organoids Identify Transepithelial Zinc Transport as a Key Mediator of Intestinal Adaptation
10.1038/s41467-024-52216-6 · 2024 · External reference
Differential Effectiveness of Dietary Zinc Supplementation With Autism‐Related Behaviours in SHANK2 Knockout Mice
10.1098/rstb.2023.0230 · 2024 · External reference
Genetic Deletion of Zinc Transporter ZnT3 Induces Progressive Cognitive Deficits in Mice by Impairing Dendritic Spine Plasticity and Glucose Metabolism
10.3389/fnmol.2024.1375925 · 2024 · External reference
10.1523/jneurosci.1980-20.2020
10.1523/jneurosci.1980-20.2020 · External reference
10.1016/j.fbio.2024.104801
10.1016/j.fbio.2024.104801 · External reference
10.1007/s11060-025-04967-5
10.1007/s11060-025-04967-5 · External reference
10.1016/j.taap.2025.117298
10.1016/j.taap.2025.117298 · External reference
Calcium Channel Blocker Amlodipine Suppresses Bladder Cancer by Regulating NFAT2 and Enhances Anti‐PD1 Immune Checkpoint Inhibitor Therapy
2025 · External reference
10.3390/cancers17203289
10.3390/cancers17203289 · External reference
10.1016/j.ejphar.2024.176919
10.1016/j.ejphar.2024.176919 · External reference
10.3748/wjg.v30.i4.367
10.3748/wjg.v30.i4.367 · External reference
10.1007/s12288-024-01804-z
10.1007/s12288-024-01804-z · External reference
10.1016/j.lansea.2024.100495
10.1016/j.lansea.2024.100495 · External reference
10.1097/ms9.0000000000002796
10.1097/ms9.0000000000002796 · External reference
10.1016/j.bcmd.2012.10.006
10.1016/j.bcmd.2012.10.006 · External reference
10.1111/j.1365-2141.2009.07609.x
10.1111/j.1365-2141.2009.07609.x · External reference
10.1002/ajh.23876
10.1002/ajh.23876 · External reference
10.1016/s2468-1253(22)00270-9
10.1016/s2468-1253(22)00270-9 · External reference
10.1016/s2468-1253(17)30293-5
10.1016/s2468-1253(17)30293-5 · External reference
10.1007/s00415-020-09746-y
10.1007/s00415-020-09746-y · External reference
Effects of Oral Administration of Zinc and Diiodohydroxyquinolein on Plasma Zinc Levels of Uremic Patients
1995 · External reference
Zinc Supplementation of Chelation Therapy in Saturnism. Preliminary Study
1992 · External reference
10.1097/cad.0000000000000947
10.1097/cad.0000000000000947 · External reference
Urinary Calcium and Bone Resorption Markers During 3 Years of Denosumab Treatment in Pediatric Osteogenesis Imperfecta
10.1093/jbmrpl/ziaf140 · 2025 · External reference
10.1093/neuonc/nox020
10.1093/neuonc/nox020 · External reference
10.3390/ijms21207660
10.3390/ijms21207660 · External reference
10.21037/atm-20-3090
10.21037/atm-20-3090 · External reference
10.1039/d5ra07832f
10.1039/d5ra07832f · External reference
Transition From Zinc Salts to Trientine Tetrahydrochloride in a Cohort of Adult Patients With Wilson Disease: The Zicup Study
10.1186/s13023-026-04311-8 · 2026 · External reference
10.1007/s10787-026-02135-3
10.1007/s10787-026-02135-3 · External reference
10.3390/ijms27021099
10.3390/ijms27021099 · External reference
10.3390/pharmaceutics17091237
10.3390/pharmaceutics17091237 · External reference
10.1097/mpg.0000000000003531
10.1097/mpg.0000000000003531 · External reference
Prolonged Zinc Use for Dysgeusia Causing Copper Deficiency
10.1017/s1478951525101478 · 2026 · External reference
10.1007/s00277-018-3407-5
10.1007/s00277-018-3407-5 · External reference
Severe Copper Sulphate Poisoning: A Case Rescued With Plasmapheresis
10.1177/00494755231151256 · 2023 · External reference
10.1631/jzus.b2400305
10.1631/jzus.b2400305 · External reference
Clinical Management of Wilson Disease
10.21037/atm.2019.03.18 · 2019 · External reference
Current Anti‐Copper Therapies in Management of Wilson Disease
10.21037/atm.2019.02.48 · 2019 · External reference
Effects of Heyndrickxia Coagulans on Waterborne Copper Toxicity
2025 · External reference
10.1016/j.jhep.2023.11.023
10.1016/j.jhep.2023.11.023 · External reference
10.2174/1566523220999200716111502
10.2174/1566523220999200716111502 · External reference
10.1016/j.ebiom.2026.106294
10.1016/j.ebiom.2026.106294 · External reference
10.1038/s41392-022-01134-4
10.1038/s41392-022-01134-4 · External reference
Essentiality, Toxicology and Chelation Therapy of Zinc and Copper
10.2174/092986705774462950 · 2005 · External reference
Zinc Chelation Therapy Mitigates Muscle Fibrosis and Improves Functional Outcomes in a Murine Model of Crush Syndrome
10.1016/j.jos.2025.12.009 · 2026 · External reference
The Predictive Value of Low Plasma Copper and High Plasma Zinc in Detecting Zinc‐induced Copper Deficiency
10.1177/0004563215620821 · 2016 · External reference
The Role of the Clinical Biochemist in Detection of Zinc‐Induced Copper Deficiency
10.1177/0004563215595429 · 2016 · External reference
Wilson Disease: Novel Diagnostic and Therapeutic Approaches
10.1055/a-2460-8999 · 2025 · External reference
10.1016/j.spinee.2024.06.018
10.1016/j.spinee.2024.06.018 · External reference
Acute Zinc Sulfate Overdose: Clinical Presentation and Management
10.1136/bcr-2024-263899 · 2025 · External reference
10.1016/j.annemergmed.2025.06.009
10.1016/j.annemergmed.2025.06.009 · External reference
Paracetamol: Mechanism of Action, Applications and Safety Concern
2014 · External reference
Metal Fume Fever: An Underdiagnosis
2023 · External reference
10.5694/j.1326-5377.1995.tb138446.x
10.5694/j.1326-5377.1995.tb138446.x · External reference
Efficacy of Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania: Study Protocol for a Randomised Controlled Trial
10.1136/bmjpo-2025-003804 · 2025 · External reference
10.18632/oncotarget.1903
10.18632/oncotarget.1903 · External reference
Activation of Calcium‑Sensing Receptor‑Mediated Autophagy in High Glucose‑Induced Cardiac Fibrosis in Vitro
10.3892/mmr.2020.11277 · 2020 · External reference
10.1007/s11427-014-4774-3
10.1007/s11427-014-4774-3 · External reference
10.1093/jnci/djq217
10.1093/jnci/djq217 · External reference
10.3390/ijms22062785
10.3390/ijms22062785 · External reference
10.1016/j.mocell.2025.100254
10.1016/j.mocell.2025.100254 · External reference
10.1016/j.apsb.2016.11.001
10.1016/j.apsb.2016.11.001 · External reference
Thapsigargin Enhanced Chemotherapeutic Sensitivity of Irinotecan in the Inflammation‐Induced Colorectal Cancer Model in Mice
10.1038/s41598-025-34567-2 · 2026 · External reference
10.3390/molecules26247469
10.3390/molecules26247469 · External reference
10.1016/j.antiviral.2016.05.010
10.1016/j.antiviral.2016.05.010 · External reference
10.1111/j.1748-1716.1995.tb09893.x
10.1111/j.1748-1716.1995.tb09893.x · External reference
10.18632/oncotarget.6068
10.18632/oncotarget.6068 · External reference
10.1016/j.bcp.2010.09.012
10.1016/j.bcp.2010.09.012 · External reference
10.3233/cbm-203165
10.3233/cbm-203165 · External reference
Cancer Stem Cells of Hepatocellular Carcinoma Are Suppressed by the Voltage‐gated Calcium Channel Inhibitor Amlodipine
10.21873/anticanres.16682 · 2023 · External reference
10.1016/j.ceca.2022.102527
10.1016/j.ceca.2022.102527 · External reference
Voltage‐Gated Calcium Channel Antibody‐Induced Oropharyngeal Dysphagia Presenting as a Paraneoplastic Neurological Complication in Breast Cancer
2021 · External reference
Targeting Ion Channels for Cancer Therapy by Repurposing the Approved Drugs
10.1016/j.bbamem.2015.03.034 · 2015 · External reference
Inhibition of Cancer Cell Growth by Calcium Channel Antagonists in the Athymic Mouse
1992 · External reference
10.1016/j.bcp.2006.12.011
10.1016/j.bcp.2006.12.011 · External reference
10.1093/neuonc/noag131
10.1093/neuonc/noag131 · External reference
Activity of the T‐Type Calcium Channel Antagonist Mibefradil in Pancreatic Cancer Xenografts
2008 · External reference
Repurposing and Rescuing of Mibefradil, an Antihypertensive, for Cancer: A Case Study
10.1089/adt.2015.29014.ajkdrrr · 2015 · External reference
10.1007/s00109-014-1235-1
10.1007/s00109-014-1235-1 · External reference
10.1016/j.bmcl.2012.09.076
10.1016/j.bmcl.2012.09.076 · External reference
10.1016/j.bbrc.2010.10.100
10.1016/j.bbrc.2010.10.100 · External reference
10.1042/bj2710515
10.1042/bj2710515 · External reference
10.2174/156800913804486629
10.2174/156800913804486629 · External reference
Potentiation and Inhibition of Ca2+ Release‐Activated Ca2+ Channels by 2‐Aminoethyldiphenyl Borate (2‐APB) Occurs Independently of IP3 Receptors
10.1111/j.1469-7793.2001.t01-1-00003.x · 2001 · External reference
10.1038/sj.bjp.0707335
10.1038/sj.bjp.0707335 · External reference
10.1016/j.ceca.2009.10.004
10.1016/j.ceca.2009.10.004 · External reference
Inhibition of Human Prostate Cancer Proliferation in Vitro and in a Mouse Model by a Compound Synthesized to Block Ca2+ Entry
2000 · External reference
10.1007/s11095-010-0249-9
10.1007/s11095-010-0249-9 · External reference
10.1007/s10637-017-0438-z
10.1007/s10637-017-0438-z · External reference
10.1124/jpet.108.139295
10.1124/jpet.108.139295 · External reference
Discovery of Gsk2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4
10.1021/acsmedchemlett.7b00094 · 2017 · External reference
10.1038/nchembio.1835
10.1038/nchembio.1835 · External reference
10.1007/s10495-005-3275-z
10.1007/s10495-005-3275-z · External reference
10.1007/s10495-014-1007-y
10.1007/s10495-014-1007-y · External reference
10.1016/j.oraloncology.2013.12.023
10.1016/j.oraloncology.2013.12.023 · External reference
10.1371/journal.pone.0127498
10.1371/journal.pone.0127498 · External reference
10.1002/anie.201411511
10.1002/anie.201411511 · External reference
10.1016/j.jnutbio.2012.08.008
10.1016/j.jnutbio.2012.08.008 · External reference
10.1038/sj.bjp.0705920
10.1038/sj.bjp.0705920 · External reference
10.1096/fj.11-198184
10.1096/fj.11-198184 · External reference
10.1038/nature10752
10.1038/nature10752 · External reference
10.1038/nature05108
10.1038/nature05108 · External reference
10.1074/jbc.m202549200
10.1074/jbc.m202549200 · External reference
10.1016/j.ccr.2008.12.019
10.1016/j.ccr.2008.12.019 · External reference
10.1074/jbc.m411797200
10.1074/jbc.m411797200 · External reference
10.1016/j.ejphar.2007.01.012
10.1016/j.ejphar.2007.01.012 · External reference
10.1124/mol.105.021154
10.1124/mol.105.021154 · External reference
10.1016/j.chembiol.2014.08.016
10.1016/j.chembiol.2014.08.016 · External reference
Ca2+‐Store‐Dependent and ‐Independent Reversal of STIM1 Localization and Function
10.1242/jcs.023903 · 2008 · External reference
10.1038/cddis.2014.156
10.1038/cddis.2014.156 · External reference
Characterization of a Novel Crac Inhibitor That Potently Blocks Human T Cell Activation and Effector Functions
10.1016/j.molimm.2012.12.011 · 2013 · External reference
10.4161/chan.25292
10.4161/chan.25292 · External reference
10.1016/j.ceca.2012.11.005
10.1016/j.ceca.2012.11.005 · External reference
Cm3457, a Potent and Selective Oral Crac Channel Inhibitor, Suppresses T and Mast Cell Function and Is Efficacious in Rat Models of Arthritis and Asthma
2012 · External reference
10.1124/jpet.112.202788
10.1124/jpet.112.202788 · External reference
10.3109/1547691x.2014.915897
10.3109/1547691x.2014.915897 · External reference
10.1371/journal.pone.0082944
10.1371/journal.pone.0082944 · External reference
10.1038/sj.bjp.0703358
10.1038/sj.bjp.0703358 · External reference
10.1016/j.febslet.2005.02.053
10.1016/j.febslet.2005.02.053 · External reference
Possible Involvement of Inositol 1,4,5‐Trisphosphate Receptor Type 3 (IP3R3) in the Peritoneal Dissemination of Gastric Cancers
2003 · External reference
Evidence for a Proapoptotic Role of Matrix Metalloproteinase‐26 in Human Prostate Cancer Cells and Tissues
10.7150/jca.13067 · 2016 · External reference
10.1074/jbc.m112.384776
10.1074/jbc.m112.384776 · External reference
10.1111/bph.12691
10.1111/bph.12691 · External reference
10.1097/nen.0b013e318201d4d4
10.1097/nen.0b013e318201d4d4 · External reference
10.1124/pr.113.008003
10.1124/pr.113.008003 · External reference
10.1016/j.brainresbull.2025.111301
10.1016/j.brainresbull.2025.111301 · External reference
10.1186/s12943-015-0472-4
10.1186/s12943-015-0472-4 · External reference
P2y2 Receptor Activation by Nucleotides Released From Highly Metastatic Breast Cancer Cells Increases Tumor Growth and Invasion via Crosstalk With Endothelial Cells
10.1186/bcr3694 · 2014 · External reference
10.1074/jbc.m113.540047
10.1074/jbc.m113.540047 · External reference
10.1111/j.1474-8673.2007.00389.x
10.1111/j.1474-8673.2007.00389.x · External reference
10.18632/oncotarget.6240
10.18632/oncotarget.6240 · External reference
